IJDVL Close
 

Table 3: Relapse at different time intervals with reference to CD19+ B-cell counts at beginning of the study (none relapsed between 6 and 9 months)

Table 3: Relapse at different time intervals with reference to CD19+ B-cell counts at beginning of the study (none relapsed between 6 and 9 months)